Compass Therapeutics, Inc.·4

Jan 5, 4:32 PM ET

Ferneau Philip 4

4 · Compass Therapeutics, Inc. · Filed Jan 5, 2026

Insider Transaction Report

Form 4
Period: 2026-01-02
Transactions
  • Award

    Stock Option (Right to Buy)

    2026-01-02+90,00090,000 total
    Exercise: $5.17Exp: 2036-01-02Common Stock (90,000 underlying)
Footnotes (1)
  • [F1]This grant vests in full upon the earlier of (i) June 10, 2026 and (ii) the date of the next annual meeting of the Company's stockholders.

Documents

1 file
  • 4
    ownership.xmlPrimary